{
  "thread": {
    "uuid": "1533851ef8e8a72b5b82882142bcd1c8f43a2210",
    "url": "https://www.pharmacytimes.com/view/camber-launches-generic-quetiapine-tablets-usp",
    "site_full": "www.pharmacytimes.com",
    "site": "pharmacytimes.com",
    "site_section": "https://pharmacytimes.com/press-releases",
    "site_categories": [
      "shopping"
    ],
    "section_title": "Press Releases",
    "title": "Camber Launches Generic Quetiapine Tablets, USP",
    "title_full": "Camber Launches Generic Quetiapine Tablets, USP",
    "published": "2024-10-17T22:46:00.000+03:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "US",
    "main_image": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/8b58a017dde8fd335514afd76fd71dd3be1fba46-4277x2369.png?fit=crop&amp;auto=format",
    "performance_score": 0,
    "domain_rank": 10865,
    "domain_rank_updated": "2024-10-15T00:00:00.000+03:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "1533851ef8e8a72b5b82882142bcd1c8f43a2210",
  "url": "https://www.pharmacytimes.com/view/camber-launches-generic-quetiapine-tablets-usp",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": null,
  "published": "2024-10-17T22:46:00.000+03:00",
  "title": "Camber Launches Generic Quetiapine Tablets, USP",
  "text": "Key Takeaways Camber Pharmaceuticals expands its product line with Quetiapine Tablets, USP, enhancing treatment options for schizophrenia and bipolar disorders. Quetiapine is an atypical antipsychotic indicated for schizophrenia, manic, and depressive episodes in bipolar disorder. The tablets are available in multiple dosages, providing flexibility in treatment regimens. This initiative supports Camber's commitment to reducing drug shortages and improving access to essential medications. SHOW MORE Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a more affordable, high-quality treatment option.\nApproximately 3.2 million Americans are affected by schizophrenia, while 5.7 million struggle with bipolar disorders. Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a high-quality treatment option. This addition supports our ongoing commitment to reducing drug shortages and improving access to essential medications.\nQuetiapine Tablets, USP are an atypical antipsychotic indicated for the treatment of:\nSchizophrenia Bipolar I disorder, manic episodes Bipolar disorder, depressive episodes Quetiapine Tablets, USP is available in:\n25 mg | 100 count 50 mg | 100 count 100 mg | 100 count 200 mg | 100 count 300 mg | 60 & 100 count 400 mg | 100 & 500 count To learn more about Quetiapine Tablets , please visit www.camberpharma.com/quetiapine",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Economy, Business and Finance",
    "Science and Technology"
  ],
  "ai_allow": true,
  "webz_reporter": false,
  "external_links": [
    "https://url.us.m.mimecastprotect.com/s/-eVdCQWR2RUgRrOmtrtvFGuCrQ?domain=camberpharma.com/",
    "https://url.us.m.mimecastprotect.com/s/-eVdCQWR2RUgRrOmtrtvFGuCrQ",
    "https://url.us.m.mimecastprotect.com/s/-eVdCQWR2RUgRrOmtrtvFGuCrQ?domain=camberpharma.com",
    "https://www.url.us.m.mimecastprotect.com/s/-eVdCQWR2RUgRrOmtrtvFGuCrQ?domain=camberpharma.com/"
  ],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "rating": null,
  "crawled": "2024-10-18T00:03:14.419+03:00",
  "updated": "2024-10-18T00:03:14.419+03:00"
}